BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
1040223	O=C1NCc2cc(ccc12)-n1ccc2cncnc12	InChI=1S/C14H10N4O/c19-14-12-2-1-11(5-10(12)7-16-14)18-4-3-9-6-15-8-17-13(9)18/h1-6,8H,7H2,(H,16,19)	MKGSQCFIAPJYRT-UHFFFAOYSA-N	498929	US11014926, Cpd. No. 1	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498929	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498929&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129073537	459071807							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040224	O=C1NCc2cc(ccc12)-n1ccc2cncnc12	InChI=1S/C14H10N4O/c19-14-12-2-1-11(5-10(12)7-16-14)18-4-3-9-6-15-8-17-13(9)18/h1-6,8H,7H2,(H,16,19)	MKGSQCFIAPJYRT-UHFFFAOYSA-N	498929	US11014926, Cpd. No. 1	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498929	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498929&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073537	459071807							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040225	CC1NC(=O)c2ccc(cc12)-n1ccc2cncnc12	InChI=1S/C15H12N4O/c1-9-13-6-11(2-3-12(13)15(20)18-9)19-5-4-10-7-16-8-17-14(10)19/h2-9H,1H3,(H,18,20)	ULRZNIIPPXOUEZ-UHFFFAOYSA-N	498930	US11014926, Cpd. No. 2	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498930	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498930&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073564	459071808							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040226	CC1NC(=O)c2ccc(cc12)N1CCc2cncnc12	InChI=1S/C15H14N4O/c1-9-13-6-11(2-3-12(13)15(20)18-9)19-5-4-10-7-16-8-17-14(10)19/h2-3,6-9H,4-5H2,1H3,(H,18,20)	ZTRBLBASOVUVMP-UHFFFAOYSA-N	498931	US11014926, Cpd. No. 3	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498931	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498931&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073516	459071809							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040227	O=C1NCc2cc(ccc12)-n1ncc2cnccc12	InChI=1S/C14H10N4O/c19-14-12-2-1-11(5-9(12)7-16-14)18-13-3-4-15-6-10(13)8-17-18/h1-6,8H,7H2,(H,16,19)	GXYZKJIRRZBSAF-UHFFFAOYSA-N	498932	US11014926, Cpd. No. 4	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498932	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498932&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073503	459071810							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040228	O=C1NCc2nc(ccc12)-n1ccc2cnccc12	InChI=1S/C14H10N4O/c19-14-10-1-2-13(17-11(10)8-16-14)18-6-4-9-7-15-5-3-12(9)18/h1-7H,8H2,(H,16,19)	RULZSWRACPGXOA-UHFFFAOYSA-N	498933	US11014926, Cpd. No. 5	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498933	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498933&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073525	459071811							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040229	c1cc2cncnc2n1-c1ccc2cnccc2c1	InChI=1S/C15H10N4/c1-2-14(7-11-3-5-16-8-12(1)11)19-6-4-13-9-17-10-18-15(13)19/h1-10H	SWPASOBEOTWXAK-UHFFFAOYSA-N	498935	US11014926, Cpd. No. 6	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498935	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498935&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073585	459071813							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040230	Cc1ncnc2n(ccc12)-c1ccc2C(=O)NCc2c1	InChI=1S/C15H12N4O/c1-9-12-4-5-19(14(12)18-8-17-9)11-2-3-13-10(6-11)7-16-15(13)20/h2-6,8H,7H2,1H3,(H,16,20)	VWSCNSQCEYPHHL-UHFFFAOYSA-N	498936	US11014926, Cpd. No. 7	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498936	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498936&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073555	459071814							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040231	Cn1cc(cn1)-c1cn(-c2ccc3C(=O)NCc3c2)c2ncncc12	InChI=1S/C18H14N6O/c1-23-8-12(6-22-23)16-9-24(17-15(16)7-19-10-21-17)13-2-3-14-11(4-13)5-20-18(14)25/h2-4,6-10H,5H2,1H3,(H,20,25)	UDXGUYCTMQSGOM-UHFFFAOYSA-N	498937	US11014926, Cpd. No. 8	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498937	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498937&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129073540	459071815							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040232	Cn1cc(cn1)-c1cn(-c2ccc3C(=O)NCc3c2)c2ncncc12	InChI=1S/C18H14N6O/c1-23-8-12(6-22-23)16-9-24(17-15(16)7-19-10-21-17)13-2-3-14-11(4-13)5-20-18(14)25/h2-4,6-10H,5H2,1H3,(H,20,25)	UDXGUYCTMQSGOM-UHFFFAOYSA-N	498937	US11014926, Cpd. No. 8	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498937	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498937&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073540	459071815							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040233	CC1NC(=O)c2ccc(cc12)N1CCCc2cncnc12	InChI=1S/C16H16N4O/c1-10-14-7-12(4-5-13(14)16(21)19-10)20-6-2-3-11-8-17-9-18-15(11)20/h4-5,7-10H,2-3,6H2,1H3,(H,19,21)	RIRJITMKDHSTFH-UHFFFAOYSA-N	498938	US11014926, Cpd. No. 9	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>57000							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498938	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498938&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073521	459071816							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040234	O=C1NCc2cc(ccc12)-c1nccc2C(=O)NCc12	InChI=1S/C15H11N3O2/c19-14-10-2-1-8(5-9(10)6-17-14)13-12-7-18-15(20)11(12)3-4-16-13/h1-5H,6-7H2,(H,17,19)(H,18,20)	BFXRXRZGYGDGSA-UHFFFAOYSA-N	498939	US11014926, Cpd. No. 10	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>57000							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498939	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498939&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073510	459071817							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040235	O=C1NCc2cc(ncc12)-n1ccc2cnccc12	InChI=1S/C14H10N4O/c19-14-11-8-16-13(5-10(11)7-17-14)18-4-2-9-6-15-3-1-12(9)18/h1-6,8H,7H2,(H,17,19)	DCYXFWOTGKEJPX-UHFFFAOYSA-N	498940	US11014926, Cpd. No. 11	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498940	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498940&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073567	459071818							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040236	Nc1ncnc2n(ccc12)-c1ccc2C(=O)NCc2c1	InChI=1S/C14H11N5O/c15-12-11-3-4-19(13(11)18-7-17-12)9-1-2-10-8(5-9)6-16-14(10)20/h1-5,7H,6H2,(H,16,20)(H2,15,17,18)	RVTDIVKORNRBTB-UHFFFAOYSA-N	498941	US11014926, Cpd. No. 12	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498941	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498941&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073512	459071819							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040237	C1SCc2cc(ccc12)-n1ccc2cncnc12	InChI=1S/C14H11N3S/c1-2-13(5-12-8-18-7-11(1)12)17-4-3-10-6-15-9-16-14(10)17/h1-6,9H,7-8H2	YRJBRILVGJWTRY-UHFFFAOYSA-N	498942	US11014926, Cpd. No. 13	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498942	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498942&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073568	459071820							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040238	O=C1NCc2nc(ncc12)-n1ccc2cnccc12	InChI=1S/C13H9N5O/c19-12-9-6-16-13(17-10(9)7-15-12)18-4-2-8-5-14-3-1-11(8)18/h1-6H,7H2,(H,15,19)	VKSUPYUKXSBRHL-UHFFFAOYSA-N	498943	US11014926, Cpd. No. 14	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498943	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498943&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073589	459071821							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040239	O=C1Cc2cc(ccc2N1)-n1ccc2cncnc12	InChI=1S/C14H10N4O/c19-13-6-10-5-11(1-2-12(10)17-13)18-4-3-9-7-15-8-16-14(9)18/h1-5,7-8H,6H2,(H,17,19)	LJAIQTDUDDSNIT-UHFFFAOYSA-N	498944	US11014926, Cpd. No. 15	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		>57000							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498944	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498944&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073535	459071822							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040240	O=C1NCc2cc(ccc12)-n1cnc2cncnc12	InChI=1S/C13H9N5O/c19-13-10-2-1-9(3-8(10)4-15-13)18-7-17-11-5-14-6-16-12(11)18/h1-3,5-7H,4H2,(H,15,19)	SFJWXHXXPIDNRS-UHFFFAOYSA-N	498945	US11014926, Cpd. No. 16	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498945	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498945&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073579	459071823							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040241	CC1NC(=O)c2c1cc(cc2Cl)-n1ccc2cncnc12	InChI=1S/C15H11ClN4O/c1-8-11-4-10(5-12(16)13(11)15(21)19-8)20-3-2-9-6-17-7-18-14(9)20/h2-8H,1H3,(H,19,21)	DIBVCVHQDKYHEP-UHFFFAOYSA-N	498946	US11014926, Cpd. No. 17	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498946&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129073549	459071824							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040242	CC1NC(=O)c2c1cc(cc2Cl)-n1ccc2cncnc12	InChI=1S/C15H11ClN4O/c1-8-11-4-10(5-12(16)13(11)15(21)19-8)20-3-2-9-6-17-7-18-14(9)20/h2-8H,1H3,(H,19,21)	DIBVCVHQDKYHEP-UHFFFAOYSA-N	498946	US11014926, Cpd. No. 17	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498946&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073549	459071824							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040243	CC1(C)NC(=O)c2c1cc(cc2Cl)-n1ccc2cncnc12	InChI=1S/C16H13ClN4O/c1-16(2)11-5-10(6-12(17)13(11)15(22)20-16)21-4-3-9-7-18-8-19-14(9)21/h3-8H,1-2H3,(H,20,22)	HUYUCTWVGNTZRI-UHFFFAOYSA-N	498947	US11014926, Cpd. No. 18	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		<10							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498947	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498947&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129073576	459071825							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040244	CC1(C)NC(=O)c2c1cc(cc2Cl)-n1ccc2cncnc12	InChI=1S/C16H13ClN4O/c1-16(2)11-5-10(6-12(17)13(11)15(22)20-16)21-4-3-9-7-18-8-19-14(9)21/h3-8H,1-2H3,(H,20,22)	HUYUCTWVGNTZRI-UHFFFAOYSA-N	498947	US11014926, Cpd. No. 18	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498947	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498947&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073576	459071825							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040245	O=C1NCc2cc(ccc12)-n1cc(-c2ccncc2)c2cncnc12	InChI=1S/C19H13N5O/c25-19-15-2-1-14(7-13(15)8-22-19)24-10-17(12-3-5-20-6-4-12)16-9-21-11-23-18(16)24/h1-7,9-11H,8H2,(H,22,25)	SWDLTXQVKXXZIQ-UHFFFAOYSA-N	498948	US11014926, Cpd. No. 19	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498948	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498948&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073504	459071826							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040246	COC(=O)NCC1NC(=O)c2ccc(cc12)-n1ccc2cncnc12	InChI=1S/C17H15N5O3/c1-25-17(24)19-8-14-13-6-11(2-3-12(13)16(23)21-14)22-5-4-10-7-18-9-20-15(10)22/h2-7,9,14H,8H2,1H3,(H,19,24)(H,21,23)	YMLJIQWEQPSVCO-UHFFFAOYSA-N	498949	US11014926, Cpd. No. 20	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498949	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498949&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129087028	459071827							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040247	NCC1NC(=O)c2ccc(cc12)-n1ccc2cncnc12	InChI=1S/C15H13N5O/c16-6-13-12-5-10(1-2-11(12)15(21)19-13)20-4-3-9-7-17-8-18-14(9)20/h1-5,7-8,13H,6,16H2,(H,19,21)	LLKQGNZLZQBWQS-UHFFFAOYSA-N	498950	US11014926, Cpd. No. 21	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498950	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498950&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073592	459071828							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040248	CC1NC(=O)c2c1cc(cc2C)-n1ccc2cncnc12	InChI=1S/C16H14N4O/c1-9-5-12(6-13-10(2)19-16(21)14(9)13)20-4-3-11-7-17-8-18-15(11)20/h3-8,10H,1-2H3,(H,19,21)	OPZFLEPCEIJFSE-UHFFFAOYSA-N	498951	US11014926, Cpd. No. 22	MAP kinase-interacting serine/threonine-protein kinase 1	Homo sapiens		 55							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498951&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search			129073545	459071829							1	MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL		MAP kinase-interacting serine/threonine-protein kinase 1	MKNK1_HUMAN	Q9BUB5	D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040249	CC1NC(=O)c2c1cc(cc2C)-n1ccc2cncnc12	InChI=1S/C16H14N4O/c1-9-5-12(6-13-10(2)19-16(21)14(9)13)20-4-3-11-7-17-8-18-15(11)20/h3-8,10H,1-2H3,(H,19,21)	OPZFLEPCEIJFSE-UHFFFAOYSA-N	498951	US11014926, Cpd. No. 22	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498951&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073545	459071829							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040250	Fc1cc(cc2CNC(=O)c12)-n1ccc2cncnc12	InChI=1S/C14H9FN4O/c15-11-4-10(3-9-6-17-14(20)12(9)11)19-2-1-8-5-16-7-18-13(8)19/h1-5,7H,6H2,(H,17,20)	JHRLBLPNIJSXEX-UHFFFAOYSA-N	498952	US11014926, Cpd. No. 23	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498952	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498952&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073586	459071830							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040251	Clc1ccccc1-c1cn(-c2ccc3C(=O)NCc3c2)c2ncncc12	InChI=1S/C20H13ClN4O/c21-18-4-2-1-3-15(18)17-10-25(19-16(17)9-22-11-24-19)13-5-6-14-12(7-13)8-23-20(14)26/h1-7,9-11H,8H2,(H,23,26)	UISASVKLUHNFCS-UHFFFAOYSA-N	498953	US11014926, Cpd. No. 24	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498953	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498953&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073554	459071831							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040252	O=C1NCc2cc(ccc12)-n1cc(-c2cscn2)c2cncnc12	InChI=1S/C17H11N5OS/c23-17-12-2-1-11(3-10(12)4-19-17)22-6-14(15-7-24-9-21-15)13-5-18-8-20-16(13)22/h1-3,5-9H,4H2,(H,19,23)	GXWJBSRLNSTGJF-UHFFFAOYSA-N	498954	US11014926, Cpd. No. 25	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498954&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073597	459071832							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040253	O=C1NCc2cc(ccc12)-n1cc(-c2ccccc2C#N)c2cncnc12	InChI=1S/C21H13N5O/c22-8-13-3-1-2-4-16(13)19-11-26(20-18(19)10-23-12-25-20)15-5-6-17-14(7-15)9-24-21(17)27/h1-7,10-12H,9H2,(H,24,27)	GCCMITIBYBDWSV-UHFFFAOYSA-N	498955	US11014926, Cpd. No. 26	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 5050							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498955	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498955&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073539	459071833							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040254	Clc1cc(cc2c1C(=O)NC21CCCC1)-n1ccc2cncnc12	InChI=1S/C18H15ClN4O/c19-14-8-12(23-6-3-11-9-20-10-21-16(11)23)7-13-15(14)17(24)22-18(13)4-1-2-5-18/h3,6-10H,1-2,4-5H2,(H,22,24)	IUAVWKRVQKKYQV-UHFFFAOYSA-N	498956	US11014926, Cpd. No. 27	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498956	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498956&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073578	459071834							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040255	Nc1ncnc2n(ccc12)-c1cc2c(C(=O)NC22CCCCC2)c(Cl)c1	InChI=1S/C19H18ClN5O/c20-14-9-11(25-7-4-12-16(21)22-10-23-17(12)25)8-13-15(14)18(26)24-19(13)5-2-1-3-6-19/h4,7-10H,1-3,5-6H2,(H,24,26)(H2,21,22,23)	OKBWEVWLBPKEED-UHFFFAOYSA-N	498957	US11014926, Cpd. No. 28	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498957&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073588	459071835							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040256	Clc1cc(cc2c1C(=O)NC21CCCCC1)-n1ccc2cncnc12	InChI=1S/C19H17ClN4O/c20-15-9-13(24-7-4-12-10-21-11-22-17(12)24)8-14-16(15)18(25)23-19(14)5-2-1-3-6-19/h4,7-11H,1-3,5-6H2,(H,23,25)	MTPOPUUVVOGOCD-UHFFFAOYSA-N	498958	US11014926, Cpd. No. 29	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		 55							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498958	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498958&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073559	459071836							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1040257	Nc1ncnc2n(ccc12)-c1cc2c(C(=O)NC22CCCC2)c(Cl)c1	InChI=1S/C18H16ClN5O/c19-13-8-10(24-6-3-11-15(20)21-9-22-16(11)24)7-12-14(13)17(25)23-18(12)4-1-2-5-18/h3,6-9H,1-2,4-5H2,(H,23,25)(H2,20,21,22)	NKJYPAMTKVPLBE-UHFFFAOYSA-N	498959	US11014926, Cpd. No. 30	MAP kinase-interacting serine/threonine-protein kinase 2	Homo sapiens		<10							US Patent		10.7270/Q2FX7DK6		aid1805587	US11014926	Sprengeler, PA; Reich, SH; Ernst, JT; Webber, SE	5/25/2021	11/22/2021	eFFECTOR Therapeutics, Inc.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=498959	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=498959&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search			129073530	459071837							1	MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA	2AC5,2HW7,6CJ5,6CJE,6CJH,6CJW,6CJY,6CK3,6CK6,6CKI	MAP kinase-interacting serine/threonine-protein kinase 2	MKNK2_HUMAN	Q9HBH9	Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
